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Abstract
Objective: To investigate the effectiveness of comprehensive medical intervention in improving the
nutritional status of elderly hemodialysis patients.
Methods: A total of 21 elderly patients on hemodialysis were treated with diet guidance,
erythropoietin, adequate dialysis, hemodiafiltration, and correction of metabolic acidosis. Quality
of life, nutritional status, and plasma amino acids were assessed in these patients before treatment,
and at 6 and 12 months after treatment.
Results: The general clinical situation of the patients was much improved, and the nutritional
status of the patients was also improved after treatment, especially 12 months later. The serum
levels of fibronectin, hematocrit, and hemoglobin were significantly increased after 12 months.
After the treatment, the pattern of plasma amino acids was also largely changed.
Conclusion: Comprehensive medical intervention should be taken to improve the nutritional status
of elderly patients on hemodialysis.
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INTRODUCTION
Malnutrition is frequently present in patients on hemo-
dialysis (1,2). With increasing age, elderly patients on
hemodialysis may be more easily affected by mal-
nutrition, which is largely responsible for the mor-
bidity and mortality of these patients. The nutritional
status of elderly patients on hemodialysis is of great
importance because it affects not only their number of
years on dialysis, but their quality of life (QOL) as well.
In this study, 21 elderly patients on hemodialysis with
mild-to-moderate malnutrition were comprehensively
treated with diet guidance, erythropoietin (EPO),
correction of metabolic acidosis, adequate dialysis, and
hemodiafiltration (HDF). The results were encouraging.
Hong Kong Journal of Nephrology, October 2001
©2001 Hong Kong Society of Nephrology
85
Hong Kong J Nephrol 2001;3(2):84-88. YQ GE, et al
METHODS
Characteristics of patients
After obtaining informed consent for participation in the
study and approved by the Ethics Committee of the
Zhong Shan Hospital, 21 elderly patients (14 men, seven
women) who had been undergoing maintenance
hemodialysis therapy for at least 6 months and were
considered to be clinically stable were included. Their
ages ranged from 65 to 80 years (mean, 70.7 years). The
causes of renal failure were glomerulonephritis (15
patients), interstitial nephritis (three), and hypertension
(three). The endogenous creatinine clearance of the
patients ranged from 3.3 to 7.2 mL per minute. Bicar-
bonate dialysis was performed three times a week and
each lasted 4.5 hours. The artificial kidney contained a
polysulfonated membrane with a surface area of 1.3 to
1.5 m2. Blood and dialysate flow rate were generally set
at 220 to 250 mL per minute and 500 mL per minute
during the dialysis, respectively. Fifteen healthy subjects
(nine men, six women) with a mean age of 69.6 years
were selected as normal controls.
Procedures
To assess QOL of the patients, Ferrans and Powers’ (3)
QOL index (dialysis version) was adopted. One of the
domains was chosen, namely psychological/spiritual
subscale, to measure the level of satisfaction of personal
spirit. The score was measured and reviewed by two
clinical psychologists and a renal physician.
The episodes of intolerance to dialysis, angina pectoris,
cardiac arrhythmia, muscle cramp, and hypotension
during dialysis within a period of 2 weeks were recorded
by one physician before treatment, and at 6 and 12
months after treatment.
The nutritional status of all the elderly patients was
evaluated by indices including relative body weight,
midarm muscle circumference, triceps skinfold thickness,
albumin, transferrin, prealbumin, and fibronectin. The
methods to assess these indices have been described
previously (1). Most of the above indices in these patients
were below normal ranges (Table 1), which indicated
that they were malnourished. Nutritional assessment was
performed before the start of therapy, and at 6 and 12
months after the treatment.
Plasma amino acid assay was performed by using an auto
amino acid analyzer (model 835-50; Hitachi, Japan).
Design of treatment
Under the guidance of physicians and a dietitian, the
patients were encouraged to consume an individualized
diet according to their nutritional status. The average
daily intake of protein required was 1 to 1.2 g/kg, more
than 50% of which was essential amino acids. Foods
such as egg, dairy products, fish, poultry, and lean meat
were consumed to maintain the above daily protein
requirement. The average energy intake was 138 to 147
kJ/kg. Fresh vegetables and fruit were consumed every
day. Vitamins B1 and B2, calcium carbonate, and 1,25-
vitamin D3 were also supplemented via tablets.
The dosage for the administration of EPO (Amgen
Greater China Ltd, Hong Kong, China) was 50 to 100
U/kg for two to three times per week to maintain the
volume of hematocrit within 30% to 33%.
Adequate dialysis urea kinetics (Kt/V) was targeted at
1.2 to 1.4. The calculation of Kt/V was derived from the
following equation (4):
Kt/V = - ln (C1/C2 - 0.08t - UF/W)
Table 1. Nutritional status of the elderly hemodialysis patients pre- and post-treatment.
Parameter Pretreatment Post-treatment Post-treatment Controls(n = 21) at 6 months (n = 21) at 12 months (n = 21)  (n = 15)
Protein intake (g/kg) 0.9 ± 0.1* 1.0 ± 0.1 1.0 ± 0.2 1.3 ± 0.2
Energy intake (kJ/kg) 117 ± 10* 126 ± 11 131 ± 12† 147 ± 12
Relative body weight (%) 89 ± 5* 90 ± 4 91 ± 5 102 ± 6
Triceps skinfold thickness (mm) 12 ± 3 13 ± 3 14 ± 4 18 ± 5
Midarm muscle circumference (mm) 201 ± 13 202 ± 11 204 ± 14 217 ± 18
Albumin (g/L) 34.3 ± 1.8* 35.6 ± 1.6 37.7 ± 2.2 43.4 ± 2.9
Transferrin (g/L) 3.18 ± 0.20* 3.26 ± 0.30 3.48 ± 0.35 3.67 ± 0.18
Prealbumin (g/L) 0.33 ± 0.05 0.33 ± 0.06 0.35 ± 0.08 0.37 ± 0.09
Fibronectin (g/L) 0.34 ± 0.02* 0.35 ± 0.02 0.37 ± 0.04† 0.42 ± 0.03
Hematocrit (%) 17.2 ± 3.7* 29.3 ± 3.8† 31.6 ± 2.9† 41.3 ± 2.5
Hemoglobin (g/L) 66 ± 11* 89 ± 7 99 ± 12† 135 ± 8
HCO3 15.5 ± 3.1 20.3 ± 4.2 21.2 ± 4.3 25.4 ± 4.6
Kt/V 1.1 ± 0.2 1.2 ± 0.2 1.2 ± 0.1
*p<0.05 compared with control group.
†p<0.05 compared with pretreatment level.
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Where K = clearance (mL/min); t = length of dialysis
(minute); V = urea distribution volume (mL); C1 =
predialysis blood urea nitrogen (mg/mL); C2 =
postdialysis blood urea nitrogen (mg/mL); UF =
ultrafiltration (mL); W = postdialysis weight (kg). The
total duration on dialysis every week was 13.5 hours.
On-line HDF, which lasted 4 hours, was performed on
the patients once a week. The replacement fluid was
infused by postdilution. The volume of substitution fluid
was 15 000 to 20 000 mL each time.
For the correction of metabolic acidosis, predialysis
blood gas was analyzed every 2 weeks. The patients took
tablets of NaHCO3 of 0.5 to 1 g three times a day if the
plasma bicarbonate was below 20 mmol/L. In some
instances, 125 to 250 mL of 5% NaHCO3 was infused
during hemodialysis.
Statistics
The results were expressed as means ± standard deviation.
Statistical analysis was performed by using analysis of
variance. The level of statistical significance was chosen
as p less than 0.05.
RESULTS
The QOL in the patients fairly improved after 12 months
of treatment (Table 2). However, the difference was not
significant. The clinical conditions including appetite,
tolerance to dialysis, episodes of cardiac arrhythmia and
angina pectoris, muscle cramp, and hypotension during
dialysis also improved moderately.
All of the nutritional indices listed in Table 1 were
improved to an extent after 6 and 12 months of treatment
compared with those before treatment. Among these
indices, energy intake, fibronectin, hemoglobin, and
hematocrit were significantly increased.
After the treatment, the pattern of plasma amino acids
of the patients was largely changed (Table 3). Some
essential amino acids such as leucine and valine increased
significantly after treatment, especially at 12 months
post-treatment. Among nonessential amino acids,
arginine, ornithine, and glycine decreased. The level of
serine increased gradually, and the increase was
significant after 12 months. The tyrosine/phenylalanine
ratio and serine/glycine ratio were also significantly
increased after 12 months.
DISCUSSION
Studies have shown that many patients on hemodialysis
have evidence of protein and energy malnutrition (1,2).
Malnutrition is usually associated with a severe clinical
Table 2. Scores of psychological/spiritual subscale from Ferrans and Powers’ (3) quality of life in 21 elderly hemodialysis patients.
Indices Pretreatment (n = 21) Post-treatmentat at 12 months (n = 21) p value
Peace of mind 17.2 ± 5.5 18.0 ± 5.3 >0.05
Faith in own religion 18.8 ± 5.0 18.7 ± 4.9 >0.05
Personal goal achievement 14.0 ± 5.7 16.0 ± 5.5 >0.05
Happiness in general 16.3 ± 6.1 19.2 ± 5.4 >0.05
Personal appearance 15.4 ± 5.1 17.3 ± 4.9 >0.05
Self 16.2 ± 5.2 17.8 ± 5.2 >0.05
Overall score 16.1 ± 4.8 18.1 ± 5.1
Table 3. Plasma amino acids (µmol/L) of the elderly hemodialysis patients pre- and post-treatment.
Parameter Pretreatment Post-treatment Post-treatment Controls(n = 21) at 6 months (n = 21) at 12 months (n = 21)  (n = 15)
Leucine 128.3 ± 26.1* 135.3 ± 18.9* 150.1 ± 20.7† 168.5 ± 20.2
Valine 170.1 ± 28.3* 182.3 ± 26.5 194.1 ± 18.3† 202.7 ± 19.4
Phenylalanine 115.5 ± 23.9 117.1 ± 21.1 101.0 ± 19.8 107.9 ± 26.4
Tryptophan 11.2 ± 4.7* 12.8 ± 5.4* 13.5 ± 4.1 20.3 ± 5.1
Arginine 95.2 ± 20.6* 84.9 ± 17.5 74.1 ± 14.3† 70.8 ± 18.1
Tyrosine 43.1 ± 14.4 48.8 ± 12.8 47.5 ± 12.7 57.3 ± 10.1
Ornithine 121.1 ± 25.9* 109.4 ± 20.1 103.8 ± 19.5† 90.2 ± 17.4
Glycine 328.5 ± 61.4* 309.6 ± 40.8 292.7 ± 48.9 276.4 ± 50.2
Serine 115.7 ± 41.6* 136.4 ± 38.3 152.1 ± 40.8† 186.5 ± 46.2
Tyrosine/phenylalanine 0.37 ± 0.11* 0.41 ± 0.09 0.48 ± 0.07† 0.54 ± 0.08
Serine/glycine 0.38 ± 0.21* 0.47 ± 0.11 0.53 ± 0.13† 0.68 ± 0.14
*p<0.05 compared with control group.
†p<0.05 compared with pretreatment level.
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outcome such as decreased QOL and increased mortality
and morbidity. There are many factors that contribute to
malnutrition; the common causes are low diet intake,
inadequate dialysis, and loss of nutrients during dialysis
and metabolic acidosis.
Because of world progress, the human lifespan is
increasing. The population of elderly patients on hemo-
dialysis has consequently grown, and malnutrition has
become more prominent in these patients (5,6). In the
Zhong Shan Hospital, malnutrition in elderly patients
on hemodialysis was characterized by decreased energy
intake, body weight, triceps skinfold thickness, and low
levels of serum albumin, transferrin, and fibronectin. The
metabolism in elderly patients decreases as many of their
organ functions decline. Their needs for nutrients
decreases, which explain why elderly patients usually
consume less food than the young do. In addition, in-
adequate dialysis, gastrointestinal diseases, drugs, and
psychosocial and socioeconomic factors further decrease
their appetite and restrict food intake. Some nutrients
such as essential amino acids and glucose lost during
dialysis, which also aggravate the nutritional status of
elderly patients on hemodialysis. Because malnutrition
can cause unfavorable clinical outcome, it is important
to improve the nutritional status of these patients.
After 12 months of comprehensive medical intervention
with diet guidance, EPO, adequate dialysis, regular HDF,
and correction of metabolic acidosis, the nutrition status
in these elderly patients improved in different extents.
The clinical condition and QOL of the patients
significantly improved. These results indicate that
nutritional improvement could reduce complications of
dialysis and improve QOL.
In collaboration with a dietitian and doctors, each patient
designed their diet individually. For hemodialysis
patients, the recommended energy intake was above 147
kJ/kg, and protein intake above 1.2 g/kg per day. Most
of the proteins were required to be of high biological
quality rich of essential amino acid (7). Because of the
different educational backgrounds and diet habit among
the patients, individual diet guidance by dietitian and
doctors was necessary. With the diet guidance, the
patients were encouraged to consume food to the required
standard. After 12 months of treatment, the energy intake
of these patients increased significantly, which had
played an important role in improving their nutrition
status.
Human recombinant EPO has been widely used to treat
anemia in patients on hemodialysis (8). The treatment is
successful in almost all cases, and the hitherto noted
adverse effects are usually well controlled. Correcting
anemia improves appetite and thus increases food intake
of patients. However, EPO has no effect on plasma amino
acids pattern (9,10). Barany et al (11) reported an ad-
justment of fat stores and an improvement in muscle
protein content after EPO maintenance therapy. All of
these factors contributed to the improvement of the
nutritional status of the elderly hemodialysis patients.
Adequate dialysis has a pivotal part in nutrition. Adequate
dialysis reduces protein catabolism by alleviating
uneasiness of the gastrointestinal tract, metabolic
acidosis, and insulin resistance. One of the most common
indices used in assessing adequacy of dialysis is Kt/V.
The recommended Kt/V level is above 1.2, and above 1.4
at best. Adopting a high biocompatible membrane and
high-efficiency dialyzer and prolonging the length of
dialysis are several common methods to reach the
targeted Kt/V, which can ensure the adequacy of dialysis.
Hemodiafiltration, one of the modalities of renal
replacement therapy introduced in recent years, seems
to offer an optimal form of treatment in patients with
end-stage renal disease. It is a method of blood clearance
based on the principle of diffuse and convective transport
of substances through a semipermeable membrane.
There are several advantages of HDF over conventional
hemodialysis. First, HDF is highly effective in elim-
inating small-, middle-, and even large-molecular
substances. Second, the convective techniques used
increase hemodynamic stability, thereby reducing
intradialysis symptoms such as hypotension and muscle
cramp even in patients with increased cardiovascular risk,
and would be well tolerated by elderly patients (12,13).
Finally, the use of high-permeability synthetic mem-
branes in HDF provides better biological compati-
bility (14). In this study, once-weekly on-line HDF treat-
ment was proved to be reasonable and acceptable to the
elderly patients. After several months of HDF, the
episodes of refractory hypertension, recurrent heart
failure, muscle cramp, and hypotension during hemo-
dialysis decreased. All of these factors contributed to the
improvement of the nutritional status in the elderly
hemodialysis patients.
Metabolic acidosis is another major factor that causes
protein catabolism in elderly hemodialysis patients (15).
Metabolic acidosis can induce rat muscle protein and
inhibit protein synthesis (16). Serious acidosis results in
poor appetite, which further inhibit food intake and
aggravate malnutrition in hemodialysis patients. In this
study, bicarbonate dialysis was performed in all dialysis
procedures. Sodium bicarbonate tablets were spo-
radically supplemented to patients whose blood gas
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ranged from mild to moderate metabolic acidosis. These
procedures successfully assured the correction of meta-
bolic acidosis in these patients.
In conclusion, comprehensive medical intervention
focused on factors contributing to malnutrition should
be emphasized to improve the nutritional status of elderly
patients on hemodialysis.
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